135 related articles for article (PubMed ID: 28380403)
21. siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells.
Montazami N; Kheir Andish M; Majidi J; Yousefi M; Yousefi B; Mohamadnejad L; Shanebandi D; Estiar MA; Khaze V; Mansoori B; Baghbani E; Baradaran B
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):98-103. PubMed ID: 26025411
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound microbubble-mediated delivery of the siRNAs targeting MDR1 reduces drug resistance of yolk sac carcinoma L2 cells.
He Y; Bi Y; Hua Y; Liu D; Wen S; Wang Q; Li M; Zhu J; Lin T; He D; Li X; Wang Z; Wei G
J Exp Clin Cancer Res; 2011 Oct; 30(1):104. PubMed ID: 22035293
[TBL] [Abstract][Full Text] [Related]
23. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
24. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
[TBL] [Abstract][Full Text] [Related]
25. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner.
Han Q; Zhang C; Zhang J; Tian Z
Hepatology; 2011 Oct; 54(4):1179-89. PubMed ID: 21721030
[TBL] [Abstract][Full Text] [Related]
26. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
27. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
28. Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells.
Tabata M; Tsubaki M; Takeda T; Tateishi K; Tsurushima K; Imano M; Satou T; Ishizaka T; Nishida S
BMC Complement Med Ther; 2020 Mar; 20(1):84. PubMed ID: 32171300
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway.
Huang GL; Song W; Zhou P; Fu QR; Lin CL; Chen QX; Shen DY
Cell Cycle; 2017 Apr; 16(7):685-692. PubMed ID: 28272990
[TBL] [Abstract][Full Text] [Related]
30. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
31. [Reversal of multi-drug resistance in K562/A02 cells by small interference RNA of mdr1 gene].
Peng Z; Xiao ZJ; Wang Y; Liu P; Cai YL; Feng WL; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):5-7. PubMed ID: 14990067
[TBL] [Abstract][Full Text] [Related]
32. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells.
Wang X; Ji C; Ma D; Zhao J; Hou M; Yu H; Zang S
Leuk Lymphoma; 2007 Aug; 48(8):1600-9. PubMed ID: 17701592
[TBL] [Abstract][Full Text] [Related]
33. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.
Nathwani SM; Butler S; Fayne D; McGovern NN; Sarkadi B; Meegan MJ; Lloyd DG; Campiani G; Lawler M; Williams DC; Zisterer DM
Cancer Chemother Pharmacol; 2010 Aug; 66(3):585-96. PubMed ID: 20020128
[TBL] [Abstract][Full Text] [Related]
34. Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.
Liu DL; Li YJ; Yao N; Xu J; Chen ZS; Yiu A; Zhang CX; Ye WC; Zhang DM
Eur J Pharmacol; 2014 Jun; 733():34-44. PubMed ID: 24704556
[TBL] [Abstract][Full Text] [Related]
35. Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation.
Zhang J; Du Z; Pan S; Shi M; Li J; Yang C; Hu H; Qiao M; Chen D; Zhao X
ACS Appl Mater Interfaces; 2018 Jun; 10(25):21590-21600. PubMed ID: 29798663
[TBL] [Abstract][Full Text] [Related]
36. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
38. [Reversal of multi-drug resistance in ovarian cancer cell by RNA interference].
Lou JY; Peng ZL; Zheng Y; Wang H; He B; Wang HJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):413-6. PubMed ID: 16831368
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer.
Ellermeier J; Wei J; Duewell P; Hoves S; Stieg MR; Adunka T; Noerenberg D; Anders HJ; Mayr D; Poeck H; Hartmann G; Endres S; Schnurr M
Cancer Res; 2013 Mar; 73(6):1709-20. PubMed ID: 23338611
[TBL] [Abstract][Full Text] [Related]
40. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
